The largest database of trusted experimental protocols

Easysep human cd8 positive selection kit 2

Manufactured by STEMCELL
Sourced in Canada

The EasySep™ Human CD8 Positive Selection Kit II is a laboratory product designed to isolate human CD8+ T cells from a variety of sample types, including peripheral blood, cord blood, and leukapheresis samples. The kit utilizes magnetic particles and an easy-to-use, column-free procedure to positively select the desired cell population.

Automatically generated - may contain errors

10 protocols using easysep human cd8 positive selection kit 2

1

Isolation and Transcriptional Profiling of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+ T lymphocytes were isolated from PBMCs using the EasySep™ Human CD8 Positive Selection Kit II on a STEMCELL EasyEights magnet following the manufacturer’s instructions. After isolation, the CD8+ T lymphocytes obtained were quantified, and the degree of purity was above 80% (CD3-BV605 clone SK7 and CD8-V450 clone RPA-T8). An RNeasy Plus Mini Kit (Qiagen, Valencia, CA, USA) was used to extract total RNA from the samples following the manufacturer’s recommendations. RNA levels were measured using the NanoDrop ND-1000 spectrophotometer (Thermo Scientific, MA, USA). For cDNA synthesis, an RT2 First Strand kit (Qiagen) was used.
For real-time PCR reactions, an RT2 SYBR Green/ROX qPCR Master Mix (Qiagen) was used, which contains SYBR Green as a fluorophore and ROX as a passive reference. The PCR array kit used was PAHS122Z Antiviral Response (Qiagen) in accordance with the manufacturer’s instructions. Gene expression data from purified CD8+ T lymphocytes were analyzed using the comparative Ct method. For normalization of the data, an average value of the following reference genes was used: ACTβ (beta-actin), GAPDH (glyceraldehyde 3 phosphate dehydrogenase), HPRT1 (hypoxanthine phosphoribosyl transferase 1), and RPLP0 (ribosomal protein, large, P0).
+ Open protocol
+ Expand
2

Isolation of Tumor-Infiltrating CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor single-cell suspension was obtained from pieces of surgically resected solid tumors, as described previously.29 (link) Briefly, the tumors were dissected into 2 mm3 fragments and dissociated in C type gentle MACS dissociation tubes (Miltenyi Biotec) with RPMI-1640 medium. The tumor cell suspensions were then filtered through 100 µm sterile nylon mesh, washed twice with PBS+2% fetal bovine serum (FBS) and resuspended in RoboSep Buffer (Stemcell Technologies). A portion of the tumor single-cell suspensions were used for flow cytometry. The remaining portion was used for CD8+ TIL isolation with EasySep Human CD8+ Positive Selection Kit II (Stemcell Technologies). CD8+ TILs were maintained in T cell medium with 10% human serum.
+ Open protocol
+ Expand
3

Isolation and Purification of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated from human blood by Ficoll density gradient centrifugation. For adult donors in the cross-sectional cohort, CD8+ cells were enriched from PBMCs using an EasySep Human CD8 Positive Selection Kit II (STEMCELL Technologies) according to the manufacturer’s instructions. Cells were resuspended in phosphate-buffered saline (PBS) containing 0.04% bovine serum albumin (BSA). Purity was over 95% for all samples. PBMCs from cord blood were cryopreserved and thawed on the day of use in warm media for 1 h, washed once with BSM (HBSS containing 0.2% BSA, 1X HEPES, 1X penicillin-streptomycin-glutamine), and stained with fluorescent antibodies against CD3, CD4, and CD8. CD8+ cells were sorted as CD8+/CD4- cells into PBS containing 0.04% BSA. For longitudinal cohort samples, cryopreserved PBMCs were thawed on the day of use in warm media for 1 h, washed once with BSM, and stained with antibody cocktails containing fluorescent antibodies against CD8 and CD4, and DNA barcoded antibodies against CD28 and CD45RA (Supplementary Fig 1c). CD8+ cells were sorted as CD8+/CD4- cells into PBS containing 0.04% BSA. Purities of CD8+ T cells ranged from 97% to 98%. For scRNA-seq library construction, cells were diluted to ~1 ×106/mL in 100 µL PBS containing 0.04% BSA and processed within hours after they were obtained.
+ Open protocol
+ Expand
4

Neutrophil-CD8+ T Cell Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophils and CD8+ T cells were isolated from the peripheral blood of patients with aHCC or healthy donors by magnetic beads according to the manufacturer’s instruction for use in subsequent in vitro experiments (for neutrophils: EasySep Direct Human Neutrophil Isolation Kit, STEMCELL Technologies, USA, Cat# 19666; for CD8+ T cells: EasySep Human CD8 Positive Selection Kit II, STEMCELL Technologies, USA, Cat# 17853).
Purified neutrophils were used for human APO-SAA protein, 2-DG, FX-11, OSM-SMI-10B, TEPP-46, and αKG stimulations and coculture analysis. For coculture of neutrophils and T cells, a total of 1 × 106 purified neutrophils were treated with control medium, SAA (1 μg/mL), OSM-SMI-10B (50 μmol/L), or SAA (1 μg/mL) plus OSM-SMI-10B (50 μmol/L) for 12 h, and then cocultured with autologous T cells at a 1:2 ratio for 12 h in a complete RPMI-1640 medium supplemented with 2 μg/mL anti-CD3 and 2 μg/mL anti-CD28 antibodies (Biolegend, USA; Cat# 317326 & 302934). The T cells were then collected for the expression of IFNγ and TNF analysis.
+ Open protocol
+ Expand
5

Isolation of CD8+ and CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated, as previously described. CD8+ cells were then isolated from PBMCs using anti‐CD8 magnetic beads (EasySep Human CD8 Positive Selection Kit II; Stemcell Technologies), and CD4+ cells were sequentially isolated from the CD8+‐depleted PBMC pour‐off using anti‐CD4 magnetic beads (EasySep Human CD4 Positive Selection Kit II; Stemcell Technologies).
+ Open protocol
+ Expand
6

Isolation and Activation of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using Ficoll-Paque Plus (Solarbio, China) to isolate peripheral blood mononuclear cells (PBMCs) from peripheral blood by gradient separation. After washing the separated PBMCs three times with physiological saline, they were resuspended to form a single cell suspension and cell counting was performed. According to the instructions of the EasySep™ Human CD8 Positive Selection Kit II (StemCell, Canada), a certain amount of PBMCs was taken and added to a sterile flow tube, followed
by the addition of the corresponding Selection Cocktail and incubation at room temperature for three minutes. Then, RapidSpheres™ (StemCell, Canada) were added and placed in the matching magnetic pole for 3 minutes. Afterwards, wash buffer was added and washed three times. The cells were resuspended in Lonza serum-free medium (Lonza, USA) and seeded into a 24-well plate, and CD3/CD28 antibodies (StemCell, Canada) were added to the wells for 72 hours to amplify and activate CD8+ T cells.
+ Open protocol
+ Expand
7

Profiling CD8+ T Cell Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+ T cells were isolated from tumor tissue-derived single cell suspensions and PBMC using the EasySep™ Human CD8 Positive Selection Kit II (StemCell Technologies). Total RNA was isolated from 1 × 106 CD8+ T cells using the RNA Easy Mini Kit (Qiagen) according to the manufacturer’s instructions. The concentration and purity of the samples were determined by spectrophotometry with a NanoDrop© 2000c (Thermo Scientific), and the RNA integrity was assessed using a 2100 Bioanalyzer (Agilent). Complementary DNA was synthesized from 100 ng of total RNA using the iScript cDNA Synthesis Kit (BIO-RAD). The gene expression levels of BCL2L1, IL-2, IL-2R, CD27, CD40L, and the β-actin housekeeping gene were evaluated using the CFX 96™ Real-Time System (BIO-RAD). The specificity of the amplified PCR product was assessed using an Agilent DNA 1000 Kit (Agilent). The relative expression of the target genes was normalized to the expression of β-actin.
+ Open protocol
+ Expand
8

MDM-CD8+ T-cell Co-culture Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
After differentiation and polarization, MDM subsets (100,000 cells/mL, 500 μL/well) were co-cultured at a ratio of 1:4 with autologous CD8+ T-cells (2 × 106 cells/mL) in 24-well polystyrene plates (Thermo Fischer Scientific, New York, NY, USA) with and without transwells separating MDM from CD8+ T-cells (Corning, New York, NY, USA). Blood CD8+ T-cells were isolated from frozen PBMC (EasySep™ Human CD8 Positive Selection Kit II, STEMCELL Technologies, Vancouver, British Columbia, BC, Canada). Cultures were maintained for 24–48 h. Distinct individuals were evaluated for each functional assay.
+ Open protocol
+ Expand
9

Isolation and Activation of CD8+ T-cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected in heparin-containing tubes and PBMCs were isolated by Ficoll gradient centrifugation and frozen for later use following published methods (27 (link)). After an overnight incubation of thawed PBMCs, CD8+ T-cells were isolated using the EasySep™ Human CD8 Positive Selection Kit II (STEMCELL Technologies, Vancouver, British Columbia, Canada). Cells (2 × 106 cells/ml) were cultured in plates pre-coated overnight at 4°C with anti-CD3 (10 μg/mL, kindly provided by Dr. S.H. Lee, University of Ottawa) and soluble anti-CD28 antibodies (10 μg/mL, Biolegend, San Diego, CA, USA). Cells were cultured for 48 h before analysis of cell functions, as determined by time course and dose response experiments (Figure S1).
+ Open protocol
+ Expand
10

T cell subset isolation protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD3+ T cells were isolated from PBMCs using the EasySep human T cell negative selection kit (Stemcell). CD4+CD25hiCD127lo Tregs and CD3+CD25loCD127hi conventional/effector cells were purified from the CD3+ T cell fraction using the EasySep human CD4+CD127loCD25+ regulatory T cell isolation kit (Stemcell). CD8+ T cells were purified from the CD3+ T cell fraction using the EasySep human CD8 Positive Selection kit II (Stemcell), and the CD8 cell fraction was used as the CD4+ T cell fraction.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!